Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Trust Skorpios currently holds 3,271,829 shares of Akero Therapeutics, Inc. (AKRO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Trust Skorpios has been a net seller of AKRO stock. They have purchased $0 and sold $71.2M worth of shares.
Trust Skorpios's most recent insider trade was on Dec 1, 2022, when they sold 1,636,000 shares at $43.50 per share.
Trust Skorpios serves as Executive at Akero Therapeutics, Inc. (AKRO). They have executed 1 insider transactions totaling $71.2M over their tenure at the company.
Trust Skorpios holds the position of Executive at Akero Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 3 years and currently hold a stake valued at $0.
Trust Skorpios has shown a selling trading pattern, with $0 in total purchases and $71.2M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Trust Skorpios was on Dec 1, 2022, when they sold $71.2M worth of AKRO shares. This transaction involved 1,636,000 shares at $43.50 per share.
Trust Skorpios currently owns 3,271,829 shares of Akero Therapeutics, Inc. (AKRO), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Trust Skorpios's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Trust Skorpios has 1 Form 4 filings on record as an insider at Akero Therapeutics, Inc..
Set alerts for Trust Skorpios and 40,000+ other insiders.